Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
| Study name | A study to investigate CSL312 in subjects with hereditary angioedema (HAE) |
| Methods | Randomised, double‐blind, placebo‐controlled, multicentre trial |
| Participants | Adults aged 18–65 years with C1‐INH HAE or FXII/PLG HAE |
| Interventions | CSL312 (factor XIIa antagonist monoclonal antibody) Placebo |
| Outcomes | Number of HAE attacks, attack severity, pharmacokinetics, AEs |
| Starting date | 29 October 2018 |
| Contact information | CSL Behring |
| Notes | Anticipated completion date: 14 October 2021 |
